Global Deoxyribonucleic Acid (DNA) Manufacturing Market
Pharmaceuticals

Global Deoxyribonucleic Acid (DNA) Manufacturing Market Growth Prospects and Strategic Opportunities Through 2029

Uncover key drivers, emerging technologies, and competitive movements shaping the deoxyribonucleic acid (dna) manufacturing market from 2025–2034 with trusted insights from The Business Research Company

What Are The Market Size Estimates For The Deoxyribonucleic Acid (DNA) Manufacturing Market?

The deoxyribonucleic acid (DNA) manufacturing market has experienced significant growth in recent years. This market is expected to expand from $4.77 billion in 2024 to $5.58 billion in 2025, achieving a compound annual growth rate (CAGR) of 16.9%. The past growth can be linked to factors such as the emergence of genomics-based research, the expansion of biotechnology and biopharma industries, an increase in contract manufacturing organizations (CMOs), broader adoption of CRISPR and gene editing applications, and government financial backing and programs.

The deoxyribonucleic acid (DNA) manufacturing market is projected to experience substantial expansion in the coming years. By 2029, its valuation is anticipated to reach $10.28 billion, demonstrating a compound annual growth rate (CAGR) of 16.5%. This growth during the forecast period is primarily driven by factors such as the broadening of cell and gene therapy development, a rise in drug discovery efforts, heightened biodefense initiatives, increased expenditures on pandemic readiness, and the worldwide integration of biomanufacturing supply networks. Key trends anticipated during this period encompass the incorporation of next-generation sequencing (NGS), progress in mRNA and DNA vaccine development, innovations in long-read and high-fidelity synthesis techniques, the application of automation and robotics in DNA production, and the emergence of next-generation enzymatic DNA synthesis (EDS).

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27272&type=smp

Which Growth Drivers Are Shaping The Deoxyribonucleic Acid (DNA) Manufacturing Market Outlook?

The deoxyribonucleic acid (DNA) manufacturing market is projected to expand due to the escalating need for gene therapies. Gene therapies encompass techniques designed to modify or replace faulty genes to treat or prevent diseases. This heightened demand for gene therapies stems from the growing incidence of genetic conditions such as cystic fibrosis, sickle cell anemia, and certain types of inherited blindness. Deoxyribonucleic acid (DNA) manufacturing is crucial for gene therapies, as it supplies the necessary high-quality, custom DNA sequences for developing and delivering therapeutic genes capable of correcting or substituting erroneous genetic material in patients. For example, in August 2024, the Association of the British Pharmaceutical Industry, a UK-based trade association, reported that the population in the UK eligible for gene therapy treatment is anticipated to increase from 2,500 in 2021 to approximately 10,000 annually by 2028. Consequently, the surging demand for gene therapies is propelling the growth of the deoxyribonucleic acid (DNA) manufacturing market.

What Are The Primary Segmentation Parameters In The Deoxyribonucleic Acid (DNA) Manufacturing Market?

The deoxyribonucleic acid (DNA) manufacturing market covered in this report is segmented

1) By Type: Plasmid Deoxyribonucleic Acid (DNA), Synthetic Deoxyribonucleic Acid (DNA), Gene Synthesis, Oligonucleotide Synthesis

2) By Grade: Good Manufacturing Practices (GMP) Grade, Research And Development Grade

3) By Application: Cell And Gene Therapy, Vaccines, Oligonucleotide-Based Drugs, Other Applications

4) By End-Use: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations

Subsegments:

1) By Plasmid Deoxyribonucleic Acid (DNA): GMP-Grade Plasmid DNA, Non-GMP-Grade Plasmid DNA, High Copy Number Plasmids, Low Copy Number Plasmids, Bacterial Fermentation-Based Plasmid Production, Transfection-Grade Plasmid DNA

2) By Synthetic Deoxyribonucleic Acid (DNA): Enzymatic DNA Synthesis, Chemical DNA Synthesis, Long DNA Fragments, Short DNA Fragments, Single-Stranded Synthetic DNA, Double-Stranded Synthetic DNA

3) By Gene Synthesis: Custom Gene Synthesis, Standard Gene Synthesis, Complex Gene Constructs, Codon Optimization Services, Gene Library Synthesis

4) By Oligonucleotide Synthesis: DNA Oligonucleotides, Modified Oligonucleotides, Long Oligonucleotides, PCR Primers, SiRNA And Antisense Oligos, Adapter And Linker Oligos

Which Emerging Trends Are Reshaping The Deoxyribonucleic Acid (DNA) Manufacturing Market Landscape?

Major companies within the DNA manufacturing market are concentrating on developing innovative approaches, such as GMP-grade plasmid DNA production, to enhance the quality, safety, and scalability of gene and cell therapy applications. GMP-grade plasmid DNA production refers to the manufacture of plasmid DNA under Good Manufacturing Practice (GMP) conditions, which are regulatory guidelines ensuring the quality, safety, and consistency of biopharmaceutical products. For instance, in April 2025, ProBio Genomics Inc., a US-based contract development and manufacturing organization (CDMO), launched GMP Plasmid DNA Manufacturing Services in Hopewell, offering in-house analytical testing, method development, and project management. This service provides unique features, including in-house process development, analytical testing, method development, and project management, thereby eliminating the need for multiple suppliers and speeding up development timelines. The service ensures high-quality output with at least 85% supercoiled plasmid DNA content while minimizing contamination risks. ProBio also offers GMP-like plasmids with a four-week delivery timeline and full GMP-grade plasmids within three months.

Which Organizations Are At The Forefront Of The Deoxyribonucleic Acid (DNA) Manufacturing Market?

Major companies operating in the deoxyribonucleic acid (DNA) manufacturing market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, Kaneka Corporation, Catalent Inc., Charles River Laboratories International Inc., WuXi Biologics Inc., AGC Biologics Inc., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio USA Inc., Twist Bioscience Corp., Ajinomoto Bio-Pharma Services, OriGene Technologies Inc., DNA Script SAS, Eurofins Genomics LLC, Touchlight Genetics Ltd., Elegen Inc., VGXI Inc., PlasmidFactory GmbH & Co. KG.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/deoxyribonucleic-acid-dna-manufacturing-global-market-report

Which Region Holds The Greatest Opportunity For Deoxyribonucleic Acid (DNA) Manufacturing Market Expansion?

North America was the largest region in the deoxyribonucleic acid (DNA) manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deoxyribonucleic acid (DNA) manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=27272&type=smp

Browse Through More Reports Similar to the Global Deoxyribonucleic Acid (DNA) Manufacturing Market 2025, By The Business Research Company

Electronic Equipment Repair Service Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/electronic-equipment-repair-service-global-market-report

Industrial Maintenance Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/industrial-maintenance-services-global-market-report

Specialty Lighting Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/specialty-lighting-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model